Laserscope's new Lyra-i™ Laser
System has been FDA cleared for all skin types, for a wide range of indications including:

In fact, the Lyra-i system combines the longest available wavelength with a unique flat beam profile to maximize patient safety and efficacy. The unique flat beam profile consistently delivers energy in the therapeutic range to all targeted structures. The Lyra-I uniquely avoids high peak powers ensuring patient safety. All Lyra-I patients are protected by patented continuous parallel contact cooling that protects the epidermis.

These unique features provide optimal results through deep penetration to the hair bulb, deeper leg vein and to the papillary dermis for dermal remodeling while maximizing patient safety

The remarkable depth of penetration of 1064nm is due to its low scattering and epidermal transparency allowing the effective delivery of energy to deeply seated targets, such as blue and purple vessels while safely avoiding epidermal pigment. Computer adjusted fluence, delivered in adjustable pulse widths coupled with 1mm to 5mm continuously adjustable spot size is ideal for treating vessels from .5 mm to 4 mm.

Lyra-i System features and benefits

1mm to 5 mm variable and 10-mm spot size for the safe and effective treatment of facial wrinkles, leg veins, hair removal and shaving bumps.

The Lyra-i's Unique wavelength and flat beam profile maintain laser energy in the therapeutic range avoiding dangerous peak powers.

Continuous parallel contact cooling combined with 1064 nm epidermal transparency protect the epidermis, permitting the safe treatment of all-skin types, and patients with recent sun exposure.

Read clinical studies by clicking here
Sign up for a local workshop by clicking here

For more information click here or call Laserscope's Customer Response Center at (800) 356-7600, or contact your regional distributor.

Note: This product is FDA cleared for laser hair removal for all skin types.

Click here for Lyra-i Product Brochure.

Click here for Lyra-i Product Specifications.